John Carroll Murray

My current clinic trials are examining how biologic therapies may control psoriasis. These trials are attempting to identify psoriasis patients not responding to TNF-antagonists and changing the biologic strategy to control psoriasis . Other trials are using new biologic agents, such as a monoclonal antibody to IL-22 to assess the efficacy and safety in treating psoriasis.
Our keloid clinic is a specialty clinic intended to study etiologies and treatmnet options for these disfiguring fibrotic tumors. At this time we do not have any trials active for keloids.
We have completed trials using topical antioxidants for UV protection form reactive oxygen species. Other trials have studies novel topical antifungal agents for onychomycosis ( laureth -4)

Current Appointments & Affiliations

Professor of Dermatology · 2006 - Present Dermatology, Clinical Science Departments

Education, Training & Certifications

Duke University · 1977 M.D.